跳至主要内容
临床试验/ITMCTR2200006864
ITMCTR2200006864尚未招募4 期

A multicenter, prospective cohort study of Tongqiao Biyan granule in the prevention and treatment of asthma allergic rhinitis in children based on the real medical environment and the Chin

First Teaching Hospital of Tianjin University of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
3 至 13(—)
性别
All

入选标准

  • (1) having a history of asthma with allergic rhinitis, (2) being 3-13 years old (< 14 years old) , (3) having entered the Chinese childhood asthma action plan and using leisurely breathing APP, being in the Green Zone of asthma, (4) the symptoms of rhinitis (nasal obstruction, nasal discharge, sneezing, nasal itching) appeared recently (nearly 1 week) , or the symptoms of rhinitis aggravated to moderate-severe recently (nearly 1 week) ; (5) voluntary participation in the study and informed consent signed by the legal guardian or with the child (=8 years old) .

排除标准

  • (1) having diseases that need to be differentiated from AR, such as upper and lower respiratory tract infection, acute rhinosinusitis, etc. ;
  • (2) having risk factors of fatal asthma attack;
  • (3) being allergic to Tongqiao Biyan granule and its components.

研究者

相似试验